BRIEF published on 01/29/2026 at 12:25, 9 months 8 days ago Eckert & Ziegler annonce de solides performances financières en 2025 Résultats Financiers Croissance Des Ventes Revenu Net Augmentation Du Résultat D'exploitation Performances 2025
BRIEF published on 01/29/2026 at 12:25, 9 months 8 days ago Eckert & Ziegler Reports Strong Financial Performance in 2025 Financial Results Net Income Sales Growth EBIT Increase 2025 Performance
PRESS RELEASE published on 01/29/2026 at 12:20, 9 months 8 days ago Eckert & Ziegler on Track as Planned and Achieves Another Record Year in 2025 Eckert & Ziegler reports record sales and profits in 2025, with sales reaching approx. €312 million and net income approx. €48 million. Company is a leader in nuclear medicine Financial Results Eckert & Ziegler Record Year 2025 Nuclear Medicine
BRIEF published on 01/12/2026 at 15:01, 9 months 25 days ago Eckert & Ziegler participeront à la conférence JP Morgan Healthcare Conférence Sur Les Soins De Santé JP Morgan Eckert Et Ziegler Composants Isotopiques Radiopharmaceutique
BRIEF published on 01/12/2026 at 15:01, 9 months 25 days ago Eckert & Ziegler to Attend J.P. Morgan Healthcare Conference Eckert & Ziegler Healthcare Conference J.P. Morgan Radiopharmaceutical Isotope Components
PRESS RELEASE published on 01/12/2026 at 14:56, 9 months 25 days ago Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference Eckert & Ziegler SE to participate in the 44th Annual J.P. Morgan Healthcare Conference. Dr. Harald Hasselmann, CEO, will present on 14 January 2026 in San Francisco, CA Healthcare Conference Eckert & Ziegler SE J.P. Morgan Healthcare Conference Dr. Harald Hasselmann
BRIEF published on 01/08/2026 at 09:05, 9 months 29 days ago Eckert & Ziegler: A Strong Case for Investment Amidst Market Volatility Investment Growth Radiopharmaceuticals Stock Performance Radioisotopes
BRIEF published on 01/08/2026 at 09:05, 9 months 29 days ago Eckert et Ziegler : Un argument convaincant en faveur de l’investissement malgré la volatilité des marchés Croissance Investissement Produits Radiopharmaceutiques Performance Boursière Radio-isotopes
PRESS RELEASE published on 01/08/2026 at 09:00, 9 months 29 days ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY Initiation research by NuWays AG recommends buying Eckert & Ziegler SE (DE0005659700) with a target price of EUR 23, citing growth in targeted radiopharmaceuticals market and unique business positioning Buy Recommendation Target Price Eckert & Ziegler SE Radiopharmaceuticals Initiation Research
BRIEF published on 12/05/2025 at 16:15, 11 months 1 day ago Executive Board Restructuring at Eckert & Ziegler Executive Board Eckert & Ziegler Restructuring Nuclear Medicine Isotope Products
Published on 11/06/2026 at 22:15, 2 hours 54 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 12 hours 9 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 12 hours 39 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 12 hours 39 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 4 hours 54 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 4 hours 54 minutes ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 5 hours 53 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 6 hours 9 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 6 hours 36 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 19:06, 6 hours 2 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 6 hours 4 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 6 hours 7 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 6 hours 9 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
